Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Telesis Bio's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $29.54 Mil. Telesis Bio's Total Assets for the quarter that ended in Dec. 2023 was $70.41 Mil.
Therefore, Telesis Bio's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.42.
The historical rank and industry rank for Telesis Bio's Equity-to-Asset or its related term are showing as below:
TBIO'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.95 Med: 0.42 Max: 0.78
Current: 0.42
During the past 5 years, the highest Equity to Asset Ratio of Telesis Bio was 0.78. The lowest was -0.95. And the median was 0.42.
TBIO's Equity-to-Asset is ranked worse than 76.32% of 870
companies
in the Medical Devices & Instruments industry
Industry Median: 0.65
vs TBIO: 0.42
Telesis Bio Equity-to-Asset Historical Data
The historical data trend for Telesis Bio's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Telesis Bio's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Telesis Bio Equity-to-Asset Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Telesis Bio's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Telesis Bio's Equity-to-Asset falls into.
Telesis Bio Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Telesis Bio's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Telesis Bio (NAS:TBIO) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Telesis Bio Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Telesis Bio's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Telesis Bio Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services. Its products comprise of BioXp system, BioXp kits, Benchtop reagents, Coronavirus tools, and BioXp biofoundry services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TBIO has been successfully added to your 